What does Yabao Pharmaceutical Group Co., Ltd do?

Yabao Pharmaceutical Group Co., Ltd (600351.SS) operates in the Medical - Pharmaceuticals industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 600351.SS's market cap?

Yabao Pharmaceutical Group Co., Ltd (600351.SS) has a market capitalization of approximately $4.96 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does 600351.SS pay a dividend?

Yes — Yabao Pharmaceutical Group Co., Ltd (600351.SS) pays a dividend semi-annually, with a trailing-twelve-month yield of 4.88%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.

600351.SS

Yabao Pharmaceutical Group Co., Ltd

SHH·Medical, Pharmaceuticals · Healthcare

¥7.17¥0.17+2.43%

Market cap¥4.96B·Aug 26 7:00 AM UTC

Price Chart

¥7.17+¥0.17 (+2.43%)today

+11.51%CAGR +2.20%

Select date range

FromTo

Sep 26, 2002Aug 26, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)4.18%

Annual Dividend (FWD)¥0.30

Dividend Growth (5Y)+43.1%

Dividend Safety—

Payout Ratio77.1%

FCF Payout Ratio42.7%

Most Recent Dividend¥0.150

Ex-Dividend DateJun 15

Payment DateJun 15

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)+37.4%

EPS Growth (3Y)+26.9%

EPS Growth (5Y)+19.4%

Next Earnings DateMay 16

Last Report DateApr 24

Reported vs Estimate¥0.15

Earnings Surprise—

FinancialsFinancials Tab

Revenue¥2.25B

Net Income¥323.21M

Net Margin14.4%

Operating Cash Flow¥599.45M

Capital Expenditures¥32.72M

Free Cash Flow¥566.73M

Return on Equity11.5%

Return on Invested Capital2.6%

Net Cash¥887.99M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 600351.SS and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 600351.SS's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 600351.SS and 80,000+ other tickers.

About Yabao Pharmaceutical Group Co., Ltd

Yabao Pharmaceutical Group Co., Ltd researches, develops, manufactures, and sells Chinese and Western medicines, and pharmaceutical packaging materials in China and internationally. It provides pediatric products, cardiovascular and cerebrovascular products, endocrine products, women's health products, patches, and general health products. Yabao Pharmaceutical Group Co., Ltd was founded in 1978 and is based in Beijing, China.

CEO: Wei Ren
Sector: Healthcare
Industry: Medical - Pharmaceuticals
Exchange: SHH
Employees: 3,415
Website: www.yabao.com.cn

Peers

Peers Tab

603676.SS

Tibet Weixinkang Medicine Co., Ltd.

Cap

¥4.1B

600479.SS

ZhuZhou QianJin Pharmaceutical Co.,Ltd

Cap

¥5.4B

002688.SZ

Jinhe Biotechnology Co. Ltd.

Cap

¥4.1B

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 600351.SS

What does Yabao Pharmaceutical Group Co., Ltd do?: Yabao Pharmaceutical Group Co., Ltd (600351.SS) operates in the Medical - Pharmaceuticals industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 600351.SS's market cap?: Yabao Pharmaceutical Group Co., Ltd (600351.SS) has a market capitalization of approximately $4.96 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does 600351.SS pay a dividend?: Yes — Yabao Pharmaceutical Group Co., Ltd (600351.SS) pays a dividend semi-annually, with a trailing-twelve-month yield of 4.88%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.